Stay updated on Repotrectinib in Rearranged Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Repotrectinib in Rearranged Solid Tumors Clinical Trial page.

Latest updates to the Repotrectinib in Rearranged Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe footer’s site revision changed from v3.7.2 to v3.8.0, reflecting a website software update.SummaryDifference0.0%

- Check8 days agoChange DetectedA sitewide NIH notice says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs. It does not change the study record details.SummaryDifference0.2%

- Check15 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check22 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.0%

- Check43 days agoChange DetectedThe history updates reflect a capitalization normalization of the contact information label and the addition of a new revision tag (v3.7.0) to the history, replacing the previous v3.6.6 entry.SummaryDifference0.1%

- Check65 days agoChange DetectedAn additional revision tag, v3.6.6, is added to the history, replacing the previous v3.6.5. This reflects a minor update to the page's versioning metadata rather than changes to study information.SummaryDifference0.0%

Stay in the know with updates to Repotrectinib in Rearranged Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Repotrectinib in Rearranged Solid Tumors Clinical Trial page.